• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    10/24/24 6:36:21 PM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email
    SC 13G/A 1 radnet_kaminsky-sc13ga2.htm AMENDMENT NO. 2

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    INFORMATION TO BE INCLUDED

    IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c), AND

    (d) AND AMENDMENTS THERETO

    FILED PURSUANT TO RULE 13d-2

     

    (Amendment No. 2)

     

    RADNET, INC.

    (Name of Issuer)

     

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

     

    750491102

    (CUSIP Number)

     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    oRule 13d-1(b)
    xRule 13d-1(c)
    oRule 13d-1(d)

     

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 2 of 6 Pages

     

    1

    NAME OF REPORTING PERSON

     

    Sandy Nyholm Kaminsky, as trustee of the HFB Heirs’ Trust II (formerly HFB Heirs’ Family Trust)

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) o

    (b) o

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States


     

    NUMBER OF

    5

    SOLE VOTING POWER

     

    4,551,753

    SHARES

    BENEFICIALLY
    OWNED BY

    6

    SHARED VOTING POWER

     

    0

    EACH
    REPORTING
    PERSON
    7

    SOLE DISPOSITIVE POWER

     

    4,551,753

    WITH
    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,551,753

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o

     

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.158%+

    12

    TYPE OF REPORTING PERSON

     

    OO

           

    _______________________

    +Calculated using the number of outstanding shares of common stock as of August 5, 2024 reported in the Issuer's Form 10-Q filed with the U.S. Securities and Exchange Commission August 9, 2024.

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 3 of 6 Pages

     

    Item 1.Issuer.

     

    (a)          The name of the issuer is RadNet, Inc. (the “Issuer”).

     

    (b)          The address of the Issuer’s principal executive office is 1510 Cotner Avenue, Los Angeles, California 90025

     

    Item 2.Reporting Person and Security.

     

    (a)          Sandy Nyholm Kaminsky, as trustee of the HFB Heirs’ Trust II (formerly the HFB Heirs’ Family Trust) (the “Reporting Person”).

     

    (b)          The Reporting Person’s address is 400 S. Emerson Street, Denver Colorado 80209.

     

    (c)          The Reporting Person is a United States citizen.

     

    (d)          The title of the class of securities to which this statement relates is the common stock, $0.0001 par value, of the Issuer (the “Common Stock”).

     

    (e)          The CUSIP number is 750491102.

     

    Item 3.If This Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a:

     

    (a)          [  ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

     

    (b)          [  ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    (c)          [  ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);

     

    (d)          [  ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

     

    (e)          [  ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    (f)           [  ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    (g)          [  ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    (h)          [  ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 4 of 6 Pages

     

    (i)          [  ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

    (j)          [  ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

    (k)         [  ] Group, in accordance with § 240.13d-1(b)(1)(ii)(J).

     

    Not applicable.

     

    Item 4.Ownership.

     

    (a)Amount beneficially owned: 4,551,753 shares of Common Stock held by HFB Heirs’ Trust II of which the Reporting Person is the trustee.
    (b)Percent of Class: 6.15% (based on 73,957,260 outstanding shares of Common Stock as of August 5, 2024 reported in the Issuer's Form 10-Q filed August 9, 2024).
    (c)Number of shares as to which the Reporting Person has:

    (i)          Sole power to vote or to direct the vote: 4,551,753

     

    (ii)         Shared power to vote or to direct the vote: 0;

     

    (iii)        Sole power to dispose or to direct the disposition of: 4,551,753; and

     

    (iv)        Shared power to dispose or to direct the disposition of: 0.

     

    Item 5.Ownership of Five Percent or Less of a Class.

    If this Schedule is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ]

     

    Not applicable.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not applicable.

     

    Item 8.Identification and Classification of Members of the Group.

    Not applicable.

     

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 5 of 6 Pages

     

    Item 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.Certifications.

    (a)         Not applicable.

     

    (b)         Not applicable.

     

    (c)         By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     

     

     

     

     

     

     

     

     

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 6 of 6 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: October 24, 2024

    /s/ Sandy Nyhom Kaminsky
    ** Signature of Reporting Person**

       
       
      /s/ Sandy Nyholm Kaminsky, as trustee of the HFB Heirs’ Trust II
      (formerly HFB Heirs’ Family Trust)
      **Signature of Reporting Person**

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Get the next $RDNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    1/9/2026$92.00Overweight
    KeyBanc Capital Markets
    6/13/2025$69.00Buy
    B. Riley Securities
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    More analyst ratings

    $RDNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026

    LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, Dr. Gregory Sorensen, Executive Vice President and Chief Strategy Officer and Kees Wesdorp, President & CEO of RadNet Digital Health will be presenting at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 10:30 a.m. PST. A live webcast of RadNet's presentati

    1/9/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Expands to Southwest Florida with Acquisition of Radiology Regional

    LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today that it has acquired Radiology Regional, a division of LucidHealth serving Southwest Florida. The expansion brings RadNet's proven operational efficiencies and leading imaging technologies to 13 locations across Naples, Cape Coral, Fort Myers, Port Charlotte and Sarasota. In the past half-century, Radiology Regional has provided a comprehensive multi-modality offering that includes MRI, CT, PET/CT, mammography, ultrasound, X-ray and other related proc

    1/7/26 6:15:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Names Four Leaders to Expanded Executive Roles

    LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global developer of digital health solutions, announced today the promotion of four senior leaders to expanded executive roles in recognition of their decades of operational excellence and strategic growth. Effective immediately, the executive leadership changes include: Stephen Forthuber, President and Chief Operating Officer, Eastern Operations, to President and Chief Executive Officer, Eastern Operations.Norman Hames, President and Chief Operating Officer, Western Operations, to President and Chief E

    1/7/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    SEC Filings

    View All

    RadNet Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - RadNet, Inc. (0000790526) (Filer)

    1/9/26 4:15:25 PM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - RadNet, Inc. (0000790526) (Filer)

    12/4/25 5:29:49 PM ET
    $RDNT
    Medical Specialities
    Health Care

    SEC Form 424B7 filed by RadNet Inc.

    424B7 - RadNet, Inc. (0000790526) (Filer)

    12/4/25 5:29:13 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets initiated coverage on RadNet with a new price target

    KeyBanc Capital Markets initiated coverage of RadNet with a rating of Overweight and set a new price target of $92.00

    1/9/26 9:07:04 AM ET
    $RDNT
    Medical Specialities
    Health Care

    B. Riley Securities initiated coverage on RadNet with a new price target

    B. Riley Securities initiated coverage of RadNet with a rating of Buy and set a new price target of $69.00

    6/13/25 7:50:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet upgraded by Raymond James with a new price target

    Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

    3/5/25 7:50:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Financial Officer Stolper Mark exercised 35,703 shares at a strike of $6.07, increasing direct ownership by 52% to 103,715 units (SEC Form 4)

    4 - RadNet, Inc. (0000790526) (Issuer)

    12/12/25 4:15:27 PM ET
    $RDNT
    Medical Specialities
    Health Care

    EVP and Chief Legal Officer Katz David Jeffrey exercised 3,396 shares at a strike of $29.44, increasing direct ownership by 5% to 71,577 units (SEC Form 4)

    4 - RadNet, Inc. (0000790526) (Issuer)

    12/12/25 4:15:08 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Pres & COO-Eastern Operations Forthuber Stephen M sold $3,531,849 worth of shares (45,088 units at $78.33), decreasing direct ownership by 8% to 529,221 units (SEC Form 4)

    4 - RadNet, Inc. (0000790526) (Issuer)

    12/9/25 4:15:21 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Leadership Updates

    Live Leadership Updates

    View All

    The Oncology Institute Announces Addition of Board Member Mark Stolper

    CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Mark Stolper has joined the Board of Directors, effective January 2, 2026. Mr. Stolper brings significant public markets, financial and operational leadership experience to The Oncology Institute's board. Mr. Stolper serves as Executive Vice President and Chief Financial Officer of RadNet, Inc. (NASDAQ:RDNT), a position he has held since 2004. Mr. Stolper has also been a member of the Board of Directors of various publicly traded and privately held healthcare companies, including 21st Century Oncolog

    1/5/26 8:30:00 AM ET
    $RDNT
    $TOI
    Medical Specialities
    Health Care
    Medical/Nursing Services

    RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division

    Former Chief Business Leader of Philips' multi-billion-dollar Precision Diagnosis division and member of Philips' Executive CommitteeEnd-to-end responsibility for Philip's CT, MR, dXR, Ultrasound and Diagnostic Informatics (radiology software) businessesProven track record of building and managing radiology software solutions, including significant experience with AI development and commercialization LOS ANGELES, Sept. 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers and digital health solutions, announced today the appo

    9/12/24 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    11/12/24 4:51:53 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    11/4/24 1:22:38 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    10/24/24 6:36:21 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Financials

    Live finance-specific insights

    View All

    RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening

    LOS ANGELES and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT) ("RadNet"), a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today the acquisition of CIMAR UK, a leading provider of cloud-native healthcare image management solutions. CIMAR will be integrated into DeepHealth, RadNet's wholly owned subsidiary and a global leader in AI-powered health informatics, to advance connected imaging-based care. "Imaging and diagnostics sit at the forefront of care, serving as the gateway to treatment and disease management," said Kees Wesdorp, CEO and President of RadNet's Digital Health division, DeepHealt

    11/11/25 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

    Total Company Revenue increased 13.4% to $522.9 million in the third quarter of 2025 from $461.1 million in the third quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 51.6% to $24.8 million in the third quarter of 2025 from $16.4 million in the third quarter of 2024Total Company Adjusted EBITDA(1) was $84.9 million in the third quarter of 2025 as compared with $73.7 million in the third quarter of 2024, an increase of 15.2%; Digital Health reportable segment Adjusted EBITDA(1) increased 6.9% to $3.5 million in the third quarter of 2025 from $3.2 million in the third quarter of 2024Total Company Adjusted EBITDA(1) margins increa

    11/9/25 4:10:00 PM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet, Inc. Announces Date of its Third Quarter 2025 Financial Results Conference Call

    LOS ANGELES, Oct. 20, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its third quarter 2025 financial results on Monday, November 10, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet's conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1740003

    10/20/25 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care